New Zealand Reaffirms Ban On "Methods" Patents

Law360, New York (July 11, 2004, 12:00 AM EDT) -- In a lawsuit that reaffirms a key principle in New Zealand’s patent policy, Pfizer has lost an appeal seeking a reversal of a High Court decision that the company could not patent a method of treating psychotic disorders using a new compound.

The unanimous decision by the Court of Appeals affirmed the principle that methods of treating disease or illness in humans cannot be patented in New Zealand. While the compound itself could be legally protected, the way it was used could not, according to the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.